← Back to directory

Peter Tugwell

Researcher Next ID · RN-024806

Researcher · Medicine

University of Ottawa

Ottawa, Canada

Not currently recruitingFunding unknown
Works count
1,416
Citation count
155,418
H-index
155
i10-index
806

Research interests

Medicine
Economics, Econometrics and Finance
Decision Sciences
Social Sciences
Rheumatoid Arthritis Research and Therapies
Health Systems, Economic Evaluations, Quality of Life
Meta-analysis and systematic reviews
Delphi Technique in Research
Health Policy Implementation Science

Publications

  • Guidelines for Reporting Outcomes in Trial Reports

    JAMA · 2022 · https://doi.org/10.1001/jama.2022.21022

  • Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review

    Journal of Pain · 2018 · https://doi.org/10.1016/j.jpain.2018.07.009

  • AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

    BMJ · 2017 · https://doi.org/10.1136/bmj.j4008

  • Living systematic review: 1. Introduction—the why, what, when, and how

    Journal of Clinical Epidemiology · 2017 · https://doi.org/10.1016/j.jclinepi.2017.08.010

  • Guideline for opioid therapy and chronic noncancer pain

    Canadian Medical Association Journal · 2017 · https://doi.org/10.1503/cmaj.170363

  • CARE guidelines for case reports: explanation and elaboration document

    Journal of Clinical Epidemiology · 2017 · https://doi.org/10.1016/j.jclinepi.2017.04.026

  • How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

    Trials · 2016 · 10.1186/s13063-016-1555-2

  • ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

    BMJ · 2016 · https://doi.org/10.1136/bmj.i4919

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Journal of Clinical Epidemiology · 2014 · 10.1016/j.jclinepi.2013.11.013

  • Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health

    Journal of Clinical Epidemiology · 2013 · 10.1016/j.jclinepi.2013.08.005

  • Developing core outcome sets for clinical trials: issues to consider

    Trials · 2012 · 10.1186/1745-6215-13-132

  • American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

    Arthritis Care & Research · 2012 · 10.1002/acr.21596

  • What types of interventions generate inequalities? Evidence from systematic reviews

    Journal of Epidemiology & Community Health · 2012 · 10.1136/jech-2012-201257

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    Annals of the Rheumatic Diseases · 2011 · 10.1136/ard.2011.149765

  • American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Arthritis & Rheumatism · 2011 · 10.1002/art.30129

  • Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Cochrane Database of Systematic Reviews · 2011 · 10.1002/14651858.cd008794.pub2

  • GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology

    Journal of Clinical Epidemiology · 2010 · 10.1016/j.jclinepi.2010.09.011

  • OARSI recommendations for the management of hip and knee osteoarthritis

    Osteoarthritis and Cartilage · 2010 · 10.1016/j.joca.2010.01.013

  • OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

    Osteoarthritis and Cartilage · 2008 · 10.1016/j.joca.2007.12.013

  • OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence

    Osteoarthritis and Cartilage · 2007 · 10.1016/j.joca.2007.06.014

  • Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

    BMC Medical Research Methodology · 2007 · https://doi.org/10.1186/1471-2288-7-10

  • A simplified disease activity index for rheumatoid arthritis for use in clinical practice

    Lara D. Veeken · 2003 · 10.1093/rheumatology/keg072

  • Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

    The Lancet · 2000 · 10.1016/s0140-6736(00)02786-0

  • Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

    The Lancet · 1998 · https://doi.org/10.1016/s0140-6736(98)01085-x

  • Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists

    Controlled Clinical Trials · 1995 · 10.1016/0197-2456(94)00031-w

  • American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    Arthritis & Rheumatism · 1995 · 10.1002/art.1780380602

  • The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

    Arthritis & Rheumatism · 1993 · 10.1002/art.1780360601

  • How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

    PubMed · 1992

  • The american college of rheumatology 1990 criteria for the classification of fibromyalgia

    Arthritis & Rheumatism · 1990 · https://doi.org/10.1002/art.1780330203

Current projects

    No projects listed.